Pharma & Biotech
BioSig Technologies looking to unlock the future of bioelectronic medicine
BioPorto focused on flagship NGAL acute kidney-injury test but also looking at coronavirus test
Biocept is changing the way physicians examine blood work for their cancer patients
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.